R. Nakashima

发表

Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans

N. Kamei, S. Nakanishi, K. Yamane, 2011, Journal of endocrinological investigation.

Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels?

Norihiko Ohashi, C. Ito, R. Nakashima, 2008, Metabolism: clinical and experimental.

Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus.

N. Kohno, M. Okubo, S. Nakanishi, 2007, Metabolism: clinical and experimental.

Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans.

N. Kohno, W. Ohishi, S. Nakanishi, 2008, Diabetes research and clinical practice.

Fenofibrate increases high molecular weight adiponectin in subjects with hypertriglyceridemia.

S. Nakanishi, K. Yamane, R. Nakashima, 2007, Endocrine journal.

Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans.

A. Nakashima, N. Kohno, N. Kamei, 2006, The Journal of clinical endocrinology and metabolism.

Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing’s syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia

N. Kohno, S. Nakanishi, K. Yamane, 2009, Endocrine.

Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial

T. Kitamura, N. Kamei, S. Nakanishi, 2021, Diabetology International.

Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans

N. Kohno, S. Nakanishi, K. Yamane, 2015, Journal of diabetes investigation.